首页 › 肥胖症 › 佐治亚州 › South Fulton
South Fulton GA 肥胖症临床试验
12项针对 肥胖症的研究正在 South Fulton及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
招募中3 期
- Rophe Adult and Pediatric Medicine/Sky Clinical Research Network Group, Union City · 距离 8 英里
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
招募中3 期
- AURORA-2 Clinical Site, Union City · 距离 8 英里
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
招募中3 期
- Privia Medical Group Georgia LLC, Peachtree City · 距离 14 英里
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
招募中3 期
- AURORA-1 Clinical Site, Union City · 距离 8 英里
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
招募中3 期
- Rophe Adult and Pediatric Medicine/SKYCRNG, Union City · 距离 8 英里
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
招募中2 期
- Rophe Adult and Pediatric Medicine/SKYCRNG, Union City · 距离 8 英里
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
招募中3 期
- Rophe Adult and Pediatric Medicine/SKYCRNG, Union City · 距离 8 英里
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
招募中3 期欢迎健康志愿者
- ACCOMPLISH-2 Research Site, Union City · 距离 8 英里
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
招募中2 期
- Rophe Adult and Pediatric Medicine/SKYCRNG, Union City · 距离 8 英里
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
招募中4 期
- Southeast Research Specialists, Douglasville · 距离 12 英里
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
招募中3 期
- Rophe Adult and Pediatric Medicine/Sky Clinical Research Network Group, Union City · 距离 8 英里
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
招募中3 期
- ACCOMPLISH-1 Research Site, Union City · 距离 8 英里
其他城市的 肥胖症试验
- Houston, TX43 项研究
- Chicago, IL41 项研究
- New York City, NY40 项研究
- San Antonio, TX40 项研究
- Washington, DC33 项研究
- Orlando, FL32 项研究
- Dallas, TX30 项研究
- Boston, MA28 项研究
- Las Vegas, NV27 项研究
- Miami, FL27 项研究
- Baltimore, MD26 项研究
- Jacksonville, FL25 项研究
South Fulton的其他研究
- 超重11 项研究
- 非小细胞肺癌8 项研究
- 2型糖尿病7 项研究
- 肺癌7 项研究
- 乳腺癌5 项研究
- 慢性淋巴细胞白血病4 项研究
- 结直肠癌4 项研究
- 心力衰竭4 项研究
- 癌症（所有类型）3 项研究
- 前列腺癌3 项研究
- 多发性骨髓瘤3 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。